SAN DIEGO--(BUSINESS WIRE)--Leading world experts in infectious disease will convene on Saturday, April 19th, to discuss the limitations of current and emerging therapies used to combat Clostridium difficile-associated disease (CDAD), also referred to as Clostridium difficile infection (CDI). CDI is recognized as the most common cause of hospital-acquired diarrhea1.
